Literature DB >> 24140454

Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death.

Meiju Aijälä1, Merja Santaniemi, Risto Bloigu, Y Antero Kesäniemi, Olavi Ukkola.   

Abstract

Two leptin receptor single nucleotide polymorphisms, Lys109Arg and Gln223Arg, have been shown to associate with several risk factors for cardiovascular disease. In addition, we have previously shown that Arg109 and Arg223 homozygotes displayed lower intima-media thickness in our well-defined OPERA (Oulu Project Elucidating Risk of Atherosclerosis) study. This current research investigated the impact of these LEPR polymorphisms on cardiovascular events and related death as well as to total mortality in the 19-year follow-up of OPERA. Subjects were randomly selected, middle-aged drug-treated hypertensives and their age- and sex-matched control subjects recruited to the OPERA study between 1990 and 1993. Mortality and hospital events of 1045 subjects were followed up until 2009. A total of 151 coronary heart disease (CHD) and 211 cardiovascular disease (CVD) events or deaths including 58 CHD and 69 CVD deaths occurred. Furthermore, during this follow-up, a total of 165 subjects died. Logistic regression analysis was performed to assess the impact of Lys109Arg and Gln223Arg on the events and death. Further modeling was performed with Cox regression for Lys109Arg. The logistic regression analysis revealed a significant protective impact of Arg109Arg genotype on CHD (OR 0.433; CI 95% 0.217-0.863) and CVD (OR 0.540; CI 95% 0.309-0.942) events or death as well as on total mortality (OR 0.390; CI 95% 0.196-0.775) when adjusted with age, sex and study group. Even after further adjustment with BMI, smoking status, systolic blood pressure and low-density lipoprotein cholesterol, the protective effect of Arg109Arg on CHD events or death and total mortality still remained statistically significant (OR 0.463; CI 95% 0.230-0.931 and OR 0.442; CI 95% 0.218-0.896, respectively). Arg109Arg was also shown to confer protection against CHD mortality (HR 0.224; CI95% 0.055-0.919) and overall mortality (HR 0.413; CI95% 0.218-0.783) also in Cox regression analysis. In conclusion, the Arg109Arg genotype of LEPR seems to be protective from cardiovascular events and death and this phenomenon seems to be independent of the traditional risk factors for atherosclerosis.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ANOVA; Analysis of variance; Arg; Arginine; BMI; Body mass index; CHD; CI; CRH1; CVA; CVD; Cardiovascular disease; Cerebrovascular accident; Confidence interval; Coronary heart disease; Cytokine receptor homologous 1; F; Forward; Gln; Glutamine; HDL-C; HR; HWE; Hardy–Weinberg equilibrium; Hazard ratio; High-density lipoprotein cholesterol; ICD; International Classification of Diseases; LDL-C; LEPR; Lep; Leptin; Leptin receptor; Low-density lipoprotein cholesterol; Lys; Lysine; MI; Mortality; Myocardial infarction; OPERA; OR; Odds ratio; Oulu Project Elucidating Risk of Atherosclerosis; R; RIA; Radioimmunoassay; Reverse; SBP; SNP; Single nucleotide polymorphism; Systolic blood pressure; VLDL; Very low-density lipoprotein

Mesh:

Substances:

Year:  2013        PMID: 24140454     DOI: 10.1016/j.gene.2013.10.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Combined donor-recipient genotypes of leptin receptor and adiponectin gene polymorphisms affect the incidence of complications after renal transplantation.

Authors:  Sonia Mota-Zamorano; Enrique Luna; Guadalupe Garcia-Pino; Luz M González; Guillermo Gervasini
Journal:  Mol Genet Metab Rep       Date:  2020-09-12

2.  Association of polymorphisms in leptin and adiponectin genes with long-term outcomes in renal transplant recipients.

Authors:  Guillermo Gervasini; Guadalupe García-Pino; Sonia Mota-Zamorano; Enrique Luna; Montserrat García-Cerrada; María Ángeles Tormo; Juan José Cubero
Journal:  Pharmacogenomics J       Date:  2019-12-02       Impact factor: 3.550

3.  Variability in the leptin receptor gene and other risk factors for post-transplant diabetes mellitus in renal transplant recipients.

Authors:  Sonia Mota-Zamorano; Enrique Luna; Guadalupe Garcia-Pino; Luz M González; Guillermo Gervasini
Journal:  Ann Med       Date:  2019-06-01       Impact factor: 4.709

Review 4.  Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review.

Authors:  Xiao-Lin Li; Jian-Qing Sui; Lin-Lin Lu; Nan-Nan Zhang; Xin Xu; Quan-Yong Dong; Yong-Ning Xin; Shi-Ying Xuan
Journal:  Lipids Health Dis       Date:  2016-03-10       Impact factor: 3.876

Review 5.  Leptin Receptor Gene Polymorphism and the Risk of Cardiovascular Disease: A Systemic Review and Meta-Analysis.

Authors:  Lei Wu; Dali Sun
Journal:  Int J Environ Res Public Health       Date:  2017-04-03       Impact factor: 3.390

6.  Leptin Receptor Gene Polymorphisms and the Risk of Non-Alcoholic Fatty Liver Disease and Coronary Atherosclerosis in the Chinese Han Population.

Authors:  Bai-Quan An; Lin-Lin Lu; Chen Yuan; Yong-Ning Xin; Shi-Ying Xuan
Journal:  Hepat Mon       Date:  2016-04-27       Impact factor: 0.660

7.  Associations of leptin and leptin receptor genetic variants with coronary artery disease: a meta-analysis.

Authors:  Peilin Xiao; Jianli Shi; Xiaoli Liu
Journal:  Biosci Rep       Date:  2019-06-10       Impact factor: 3.840

8.  Association of leptin and leptin receptor polymorphisms with coronary artery disease in a North Chinese Han population.

Authors:  Haidong Wang; Chao Wang; Wenxiu Han; Chunmei Geng; Dan Chen; Bin Wu; Jun Zhang; Changshui Wang; Pei Jiang
Journal:  Rev Soc Bras Med Trop       Date:  2020-02-07       Impact factor: 1.581

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.